Extramotor involvement in ALS: PET studies with the GABA A ligand [ 11 C]flumazenil

ISSN： 1460-2156

Source： Brain, Vol.123, Iss.11, 2000-11, pp. : 2289-2296

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Distinct cerebral lesions in sporadic and ‘D90A’ SOD1 ALS: studies with [ 11 C]flumazenil PET

By Turner M. R.

Brain, Vol. 128, Iss. 6, 2005-06 ,pp. : 1323-1329

Oxford University Press

Access to resources Recommend Favorite

Cortical involvement in four cases of primary lateral sclerosis using [¹¹C]-flumazenil PET

By Turner Martin Hammers Alexander Al-Chalabi Ammar Shaw Christopher Andersen Peter Brooks David Leigh P.

Journal of Neurology, Vol. 254, Iss. 8, 2007-08 ,pp. : 1033-1036

Springer Publishing Company

Access to resources Recommend Favorite

Abnormalities of grey and white matter [ 11 C]flumazenil binding in temporal lobe epilepsy with normal MRI

By Hammers A.

Brain, Vol. 125, Iss. 10, 2002-10 ,pp. : 2257-2271

Oxford University Press

Access to resources Recommend Favorite

By Bouvard Sandrine

Brain, Vol. 128, Iss. 6, 2005-06 ,pp. : 1330-1343

Oxford University Press

Access to resources Recommend Favorite

Tracer Kinetic Modeling of the 5-HT_1A Receptor Ligand [carbonyl-¹¹C]WAY-100635 for PET

By Gunn R.N. Sargent P.A. Bench C.J. Rabiner E.A. Osman S. Pike V.W. Hume S.P. Grasby P.M. Lammertsma A.A.

NeuroImage, Vol. 8, Iss. 4, 1998-11 ,pp. : 426-440

Academic Press

Access to resources Recommend Favorite